[go: up one dir, main page]

CN101077338B - Nano lanthanum carbonate and orally disintegrating tablet and preparation method - Google Patents

Nano lanthanum carbonate and orally disintegrating tablet and preparation method Download PDF

Info

Publication number
CN101077338B
CN101077338B CN2006100138360A CN200610013836A CN101077338B CN 101077338 B CN101077338 B CN 101077338B CN 2006100138360 A CN2006100138360 A CN 2006100138360A CN 200610013836 A CN200610013836 A CN 200610013836A CN 101077338 B CN101077338 B CN 101077338B
Authority
CN
China
Prior art keywords
parts
lanthanum
orally disintegrating
carbonate
disintegrating tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006100138360A
Other languages
Chinese (zh)
Other versions
CN101077338A (en
Inventor
高建平
郑伍魁
谢佳烨
刘宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN2006100138360A priority Critical patent/CN101077338B/en
Publication of CN101077338A publication Critical patent/CN101077338A/en
Application granted granted Critical
Publication of CN101077338B publication Critical patent/CN101077338B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)

Abstract

本发明为纳米碳酸镧口腔崩解片及制备方法。采用干法压片将主药和辅料等在40-80℃下干燥2-4小时,过100目筛,然后压片得到口腔崩解片。辅料包括崩解剂、填充剂、泡腾剂、助流剂、润滑剂、矫味剂等。湿法压片是先将主药和部分崩解剂、填充剂、矫味剂和粘接剂混合,过30-60目筛,在40-90℃下干燥2-10小时;然后与剩余的崩解剂、填充剂、矫味剂以及泡腾剂、助流剂、润滑剂混合均匀,压片得到口腔崩解片。上述制片的压力为2-15Mpa,所得口腔崩解片硬度为2~5kg,体外崩解时间为20-80秒。该纳米碳酸镧口腔崩解片充分考虑了药物作用机理,能极大限度发挥药物的疗效,降低患者的服药量,提高患者的顺应性。

Figure 200610013836

The invention relates to a nanometer lanthanum carbonate orally disintegrating tablet and a preparation method thereof. The main drug and auxiliary materials are dried at 40-80°C for 2-4 hours by dry compression, passed through a 100-mesh sieve, and then compressed to obtain orally disintegrating tablets. Excipients include disintegrants, fillers, effervescent agents, glidants, lubricants, flavoring agents, etc. Wet tableting is to mix the main drug and some disintegrants, fillers, flavoring agents and binders, pass through a 30-60 mesh sieve, and dry at 40-90°C for 2-10 hours; then mix with the remaining The disintegrating agent, filler, flavoring agent, effervescent agent, glidant, and lubricant are mixed evenly, and compressed into tablets to obtain orally disintegrating tablets. The pressure of the above tablet making is 2-15Mpa, the obtained orally disintegrating tablet has a hardness of 2-5kg, and the disintegration time in vitro is 20-80 seconds. The nano-lanthanum carbonate orally disintegrating tablet fully considers the mechanism of drug action, can maximize the curative effect of the drug, reduce the dosage of the patient, and improve the compliance of the patient.

Figure 200610013836

Description

纳米碳酸镧口腔崩解片及制备方法Nano lanthanum carbonate orally disintegrating tablet and preparation method thereof

技术领域 technical field

本发明属于纳米材料技术领域,以及药物科学领域。The invention belongs to the technical field of nanometer materials and the field of pharmaceutical science.

背景技术 Background technique

高磷酸血症是慢性肾衰的一种并发症,80%的肾透析病人患有此症。该症可能引起骨质病变,皮肤发痒,甚至皮肤溃疡等方面的疾病外,还会造成心血管系统的损害,有50%的患者因此而死亡。服用磷结合剂是目前治疗高血磷症的主要治疗手段。Hyperphosphatemia is a complication of chronic renal failure, 80% of renal dialysis patients suffer from this disease. The disease may cause bone lesions, skin itching, and even skin ulcers, etc., and also cause damage to the cardiovascular system, and 50% of patients will die as a result. Phosphate binders are currently the mainstay of treatment for hyperphosphatemia.

磷酸盐结合剂可以螯合食物中的磷,阻止胃肠道对磷的吸收。第一代磷结合剂是铝盐,它能有效降低慢性肾衰病人血清中的磷酸盐水平,但长期使用会导致痴呆和软骨病,因而其临床应用受到了限制。含钙的磷结合剂(如醋酸钙、碳酸钙)也能降低高磷酸血症病人的血清磷水平,但会增加高钙血和钙化的发生率,这种情况在使用维生素D的患者中尤为特出,且病人对此类药物的顺应性差。因此人们希望开发研制非铝、钙型磷结合剂。1998年GenzymeGenerals和GelTex雨家制药公司生產出Renagel片劑,这也是一种用来治療行血液透析的晚期腎病患者的高血磷症的药物。Renagel是一种聚合物树脂,它携带多个胺基可在小肠内质子化而带正电荷,通过离子交换和氢键与小肠中的磷酸根结合从而降低血磷。但Renagel能否有效抑制甲状旁腺增生和降低高PTH、对血钙的水平有无影响,这方面的实验数据还有限。Phosphate binders chelate phosphorus in food, preventing its absorption from the gastrointestinal tract. The first-generation phosphorus binders are aluminum salts, which can effectively reduce the serum phosphate level in patients with chronic renal failure, but long-term use can lead to dementia and osteomalacia, so its clinical application is limited. Calcium-containing phosphate binders (eg, calcium acetate, calcium carbonate) also reduce serum phosphorus levels in patients with hyperphosphatemia but increase the incidence of hypercalcemia and calcification, especially in patients taking vitamin D Outstanding, and the patient's compliance with such drugs is poor. Therefore, people hope to develop non-aluminum, calcium-type phosphorus binders. In 1998, Genzyme Generals and GelTex Yujia Pharmaceutical Company produced Renagel tablets, which is also a drug used to treat hyperphosphatemia in patients with end-stage renal disease undergoing hemodialysis. Renagel is a polymer resin that carries multiple amine groups that can be protonated in the small intestine to be positively charged. It combines with phosphate groups in the small intestine through ion exchange and hydrogen bonding to reduce blood phosphorus. But whether Renagel can effectively inhibit parathyroid hyperplasia and reduce high PTH, and whether it has any effect on blood calcium levels, the experimental data in this area are still limited.

镧(原子序数57,原子质量159)是一种对氧供体原子有强亲和力的稀有元素,镧盐能与碳氧化合物及磷酸盐类化合物结合产生水溶性小、不易透过生物膜的磷酸镧分子。作为一种非钙、非铝的磷结合剂,氯化镧、碳酸镧等具有与传统结合剂同样降低病人血清中的磷酸盐水平的作用,而且不会导致血清钙的升高和产生严重副作用,耐受性也较好;它将会成为新一代治疗高血磷症的药物。英国先令公司推出的碳酸镧药物Fosrenl是一种咀嚼片,于2004年上市。其中有效成分碳酸镧的粒径是影响药物疗效的关键,而先令公司并未涉及碳酸镧晶体粒径的大小。现有碳酸镧晶体颗粒尺度较大,因此比表面积小,导致吸附能力不高。Lanthanum (atomic number 57, atomic mass 159) is a rare element that has a strong affinity for oxygen donor atoms. Lanthanum salts can combine with carbon oxides and phosphate compounds to produce phosphoric acid that is less water-soluble and difficult to pass through biomembranes. Lanthanum molecule. As a non-calcium, non-aluminum phosphorus binder, lanthanum chloride, lanthanum carbonate, etc. have the same effect as traditional binders on reducing the phosphate level in the patient's serum, and will not lead to an increase in serum calcium and serious side effects , and better tolerance; it will become a new generation of drugs for the treatment of hyperphosphatemia. The lanthanum carbonate drug Fosrenl launched by the British Shilling Company is a chewable tablet that was launched in 2004. Among them, the particle size of the active ingredient lanthanum carbonate is the key to affect the curative effect of the drug, and Shilling Company did not involve the particle size of the lanthanum carbonate crystal. The existing lanthanum carbonate crystal particle size is large, so the specific surface area is small, resulting in low adsorption capacity.

发明内容 Contents of the invention

为了解决现有技术的不足,本发明提出一种纳米碳酸镧口腔崩解片及制备方法和纳米碳酸镧的制备方法。In order to solve the deficiencies of the prior art, the present invention proposes a nano-lanthanum carbonate orally disintegrating tablet, a preparation method thereof and a preparation method of the nano-lanthanum carbonate.

纳米碳酸镧口腔崩解片的制备方法:The preparation method of nanometer lanthanum carbonate orally disintegrating tablet:

1).配制制剂成分:1). Preparation ingredients:

碳酸镧纳米晶:  5-40份Lanthanum carbonate nanocrystals: 5-40 parts

崩解剂:        10-70份Disintegrant: 10-70 parts

填充剂:        15-60份Filler: 15-60 parts

矫味剂:    0-5份Flavoring agent: 0-5 parts

泡腾剂:    0-5份Effervescent agent: 0-5 parts

助流剂:    0-4份Glidant: 0-4 parts

润滑剂:    0-2份Lubricant: 0-2 parts

粘接剂:    0.5-3份;Adhesive: 0.5-3 parts;

采用干法压片和湿法压片两种技术制备纳米碳酸镧口腔崩解片。干法压片是将主药和辅料等在40-80℃下干燥2-4小时,过40-100目筛,然后压片得到口腔崩解片。辅料包括崩解剂、填充剂、泡腾剂、助流剂、润滑剂、矫味剂等。湿法压片是先将主药和部分崩解剂、填充剂、矫味剂和粘接剂混合,过30-60目筛,在40-90℃下干燥2-10小时;然后与剩余的崩解剂、填充剂、矫味剂以及泡腾剂、助流剂、润滑剂混合均匀,压片得到口腔崩解片。上述制片的压力为2-15Mpa,所得口腔崩解片硬度为2~5kg,体外崩解时间为20-80秒。Orally disintegrating tablets of nano-lanthanum carbonate were prepared by two techniques of dry compression and wet compression. Dry compression is to dry the main drug and auxiliary materials at 40-80°C for 2-4 hours, pass through a 40-100 mesh sieve, and then compress to obtain orally disintegrating tablets. Excipients include disintegrants, fillers, effervescent agents, glidants, lubricants, flavoring agents, etc. Wet tableting is to mix the main drug and some disintegrants, fillers, flavoring agents and binders, pass through a 30-60 mesh sieve, and dry at 40-90°C for 2-10 hours; then mix with the remaining The disintegrating agent, filler, flavoring agent, effervescent agent, glidant, and lubricant are mixed evenly, and compressed into tablets to obtain orally disintegrating tablets. The pressure of the above tablet making is 2-15Mpa, the obtained orally disintegrating tablet has a hardness of 2-5kg, and the disintegration time in vitro is 20-80 seconds.

所述崩解剂为交联羧甲基纤维素钠(cCMC-Na)、交联羧甲基淀粉钠(CMS-Na)、低取代羟丙纤维素(LSHPC)、交联聚乙烯吡咯烷酮(PPVP)或微晶纤维素(MCC)的一种以及上述两种或两种以上的上述聚合物的组合。The disintegrating agent is cross-linked carboxymethylcellulose sodium (cCMC-Na), cross-linked carboxymethyl starch sodium (CMS-Na), low-substituted hydroxypropyl cellulose (LSHPC), cross-linked polyvinylpyrrolidone (PPVP ) or one of microcrystalline cellulose (MCC) and a combination of two or more of the above-mentioned polymers.

所述的崩解剂为交联羧甲基纤维素钠、交联羧甲基淀粉钠、低取代羟丙纤维素、交联聚乙烯吡咯烷酮或微晶纤维素的一种或两种以上的聚合物的组合。The disintegrating agent is one or more polymers of cross-linked carboxymethylcellulose sodium, cross-linked carboxymethyl starch sodium, low-substituted hydroxypropyl cellulose, cross-linked polyvinylpyrrolidone or microcrystalline cellulose combination of things.

所述的填充剂为甘露醇、四丁醇、乳糖、蔗糖、木糖醇或山梨醇的一种或两种以上的聚合物的组合。The filler is one or a combination of two or more polymers of mannitol, tetrabutanol, lactose, sucrose, xylitol or sorbitol.

所述的矫味剂为薄荷醇、薄荷油、甘草、柠檬酸、酒石酸、肉桂或香精的一种或两种以上的聚合物的组合。The flavoring agent is one or more polymers of menthol, peppermint oil, licorice, citric acid, tartaric acid, cinnamon or essence.

所述的泡腾剂为碳酸氢钠。Described effervescent agent is sodium bicarbonate.

所述的助流剂为微粉硅胶。The glidant is micronized silica gel.

所述的润滑剂为硬脂酸镁或滑石粉。Described lubricant is magnesium stearate or talcum powder.

所述的粘接剂为聚维酮、聚乙二醇、予糊化淀粉、糊精或甲基纤维素的一种或两种以上的聚合物的组合。The binder is one or a combination of two or more polymers of povidone, polyethylene glycol, pregelatinized starch, dextrin or methylcellulose.

碳酸镧纳米晶可以选用已有的产品,当然也可以用我们发明的方法制备的碳酸镧纳米晶。The lanthanum carbonate nanocrystals can be selected from existing products, and of course the lanthanum carbonate nanocrystals prepared by the method we invented can also be used.

本发明制备的纳米碳酸镧采用如下方法制备:The nano lanthanum carbonate prepared by the present invention adopts following method to prepare:

1)配制0.1-10wt%稳定剂溶液和0.01-0.9mol/L镧化合物溶液,并将两种溶液混合均匀,静置10-30分钟,将配制好的0.01-1.2mol/L碳酸盐溶液加入到上述混合溶液中,控制成核温度5-30℃,搅拌反应5-20分钟;然后在10-50℃和搅拌下继续反应30min-4h,停止搅拌,加入浓度为0.1-5wt%表面活性剂溶液,然后放置10-60分钟;1) Prepare 0.1-10wt% stabilizer solution and 0.01-0.9mol/L lanthanum compound solution, mix the two solutions evenly, let stand for 10-30 minutes, and prepare 0.01-1.2mol/L carbonate solution Add it to the above mixed solution, control the nucleation temperature at 5-30°C, stir and react for 5-20 minutes; then continue to react at 10-50°C and stir for 30min-4h, stop stirring, and add a concentration of 0.1-5wt% surface active agent solution, and then left for 10-60 minutes;

2)将上述所得产物离心沉降10-40min,并用蒸馏水洗2-4遍;然后将固体干燥产物在马弗炉中培烧1-5小时,温度控制在150-400℃,升温速率为5-10℃/min;2) Centrifuge the product obtained above for 10-40 minutes, and wash it with distilled water 2-4 times; then burn the solid dry product in a muffle furnace for 1-5 hours, the temperature is controlled at 150-400 °C, and the heating rate is 5- 10℃/min;

所述的稳定剂为天然大分子明胶、壳聚糖、海藻酸盐、胶原、淀粉、纤维素及其衍生物;或聚乙烯醇、聚羟基丁酸酯及共聚物、聚酸酐、聚乙烯基吡咯烷酮、聚氧乙烯、聚乙二醇的合成的有机大分子;或木糖醇、山梨醇、甘露醇、丙三醇的多元醇;或蔗糖、乳糖、葡萄糖的多糖或单糖;他们一种或两种以上混合使用。The stabilizer is natural macromolecular gelatin, chitosan, alginate, collagen, starch, cellulose and derivatives thereof; or polyvinyl alcohol, polyhydroxybutyrate and copolymers, polyanhydrides, polyvinyl Synthetic organic macromolecules of pyrrolidone, polyoxyethylene, polyethylene glycol; or polyols of xylitol, sorbitol, mannitol, glycerol; or polysaccharides or monosaccharides of sucrose, lactose, glucose; one of them Or a mixture of two or more.

所述的镧化合物为氯化镧、硝酸镧、硫酸镧、醋酸镧或草酸镧。The lanthanum compound is lanthanum chloride, lanthanum nitrate, lanthanum sulfate, lanthanum acetate or lanthanum oxalate.

所述的碳酸盐为碳酸钠、碳酸钾、碳酸氨、碳酸氢纳、碳酸氢钾或碳酸氢氨。Described carbonate is sodium carbonate, potassium carbonate, ammonium carbonate, sodium bicarbonate, potassium bicarbonate or ammonium bicarbonate.

所述的表面活性剂为十二烷基磺酸钠、司盘80、司盘60或吐温40。The surfactant is sodium dodecylsulfonate, Span 80, Span 60 or Tween 40.

本发明的特征之处在于:The present invention is characterized in that:

1.采用沉淀法可制备纳米尺度碳酸镧晶体,通过调节温度控制晶体的成核和晶体生长。1. Nanoscale lanthanum carbonate crystals can be prepared by the precipitation method, and the nucleation and crystal growth of the crystals can be controlled by adjusting the temperature.

2.通过调整加料方式控制晶体的大小。2. Control the crystal size by adjusting the feeding method.

3.利用稳定剂分子的吸附、稳定和空间限定作用,控制碳酸镧晶体的尺度和形状。3. Control the scale and shape of lanthanum carbonate crystals by utilizing the adsorption, stabilization and space confinement effects of stabilizer molecules.

4.加入表面活性剂可使晶体分散更均匀,防止团聚。4. Adding surfactant can make crystal dispersion more uniform and prevent agglomeration.

纳米碳酸镧口腔崩解片充分考虑了药物作用机理,能极大限度发挥药物的疗效,降低患者的服药量,提高患者的顺应性。Nano-lanthanum carbonate orally disintegrating tablets fully consider the mechanism of drug action, which can maximize the curative effect of the drug, reduce the dosage of the patient, and improve the compliance of the patient.

附图说明 Description of drawings

图1:纳米碳酸镧电镜扫描照片;Figure 1: Electron microscope scanning photo of nano-lanthanum carbonate;

图2:纳米碳酸镧电镜扫描照片局部放大图。Figure 2: Partial enlarged view of the scanning electron microscope photo of nano-lanthanum carbonate.

具体实施方式 Detailed ways

实例1Example 1

首先配制1wt%明胶溶液、0.3mol/L碳酸钠溶液、0.2mol/L氯化镧溶液待用,然后取出50ml氯化镧溶液,加入20ml明胶溶液,搅拌使之混合均匀。用冰/水混合物水浴控制温度为5℃,加入50ml碳酸钠溶液,搅拌反应10min,而后以3℃/min速度升温,直到30℃停止,在此温度下反应30min,然后加入1wt%的十二烷基磺酸钠0.2ml,并放置20min。将浊液放入离心分离机中分离30min(3000r/min下同),取出沉降物,用水洗3遍,将得到的沉降物置于坩埚中。将盛有产物的坩埚放入马弗炉中加热,升温速率为10℃/min,直到400℃,在此温度下焙烧1小时,然后自然冷却至室温,得到纳米碳酸镧晶体见附图1和2。First prepare 1wt% gelatin solution, 0.3mol/L sodium carbonate solution, and 0.2mol/L lanthanum chloride solution for use, then take out 50ml of lanthanum chloride solution, add 20ml of gelatin solution, and stir to make it evenly mixed. Use an ice/water mixture water bath to control the temperature at 5°C, add 50ml of sodium carbonate solution, stir for 10 minutes, then raise the temperature at a rate of 3°C/min until it stops at 30°C, react at this temperature for 30 minutes, and then add 1 wt% of dodecyl Sodium alkyl sulfonate 0.2ml, and left for 20min. Put the turbid liquid into a centrifuge for separation for 30 minutes (3000r/min, the same below), take out the sediment, wash with water 3 times, and place the obtained sediment in a crucible. Put the crucible containing the product into a muffle furnace and heat it at a rate of 10°C/min until 400°C, bake it at this temperature for 1 hour, and then cool it down to room temperature naturally to obtain nano-lanthanum carbonate crystals. See Figure 1 and Figure 1. 2.

实例2Example 2

首先配制0.1wt%聚氧乙烯溶液、0.06mol/L碳酸钾溶液、0.04mol/L硝酸镧溶液待用,然后取出50ml硝酸镧溶液,加入20ml聚乙二醇溶液,搅拌使之混合均匀。用冰/水混合物水浴控制温度为10℃,加入50ml碳酸钾溶液,搅拌反应15min,而后以5℃/min速度升温,直到30℃停止,并在此温度下反应50min,然后加入0.2ml浓度为0.1wt%的司盘80,并放置40min。将得到的乳浊液放入离心分离机中分离40min,取出沉降物,用水洗2遍,将得到的沉降物置于坩埚中。所坩埚放入马弗炉中焙烧,升温速率为5℃/min,直到300℃,在此温度下焙烧0.5小时,然后自然冷却至室温,得到纳米碳酸镧晶体。First prepare 0.1wt% polyoxyethylene solution, 0.06mol/L potassium carbonate solution, and 0.04mol/L lanthanum nitrate solution for use, then take out 50ml of lanthanum nitrate solution, add 20ml of polyethylene glycol solution, and stir to make it evenly mixed. Use an ice/water mixture water bath to control the temperature at 10°C, add 50ml of potassium carbonate solution, stir for 15min, then raise the temperature at a rate of 5°C/min until it stops at 30°C, and react at this temperature for 50min, then add 0.2ml of 0.1wt% Span 80, and leave it for 40min. Put the obtained emulsion into a centrifuge for separation for 40 minutes, take out the sediment, wash it twice with water, and place the obtained sediment in a crucible. The crucible was put into a muffle furnace and fired at a heating rate of 5°C/min until 300°C, fired at this temperature for 0.5 hour, and then naturally cooled to room temperature to obtain nano-lanthanum carbonate crystals.

实例3Example 3

首先配制10wt%丙三醇溶液、1.2mol/L碳酸氢氨溶液、0.9mol/L醋酸化镧溶液待用,然后取出100ml醋酸镧溶液,加入2ml丙三醇溶液,搅拌使之混合均匀。用冰/水混合物水浴控制温度为15℃,逐滴加入100ml碳酸氢氨溶液,20分钟加完,搅拌反应5min,而后以2℃/min速度升温,直到25℃停止,在此温度下反应70min,然后加入0.5ml浓度为5wt%的吐温40,并放置30min。将浊液放入离心分离机中分离20min,取出沉降物,用水洗4遍,将得到的沉降物置于坩埚中。将盛有产物的坩埚放入马弗炉中加热,升温速率为10℃/min,直到250℃,在此温度下焙烧1小时,然后自然冷却至室温,得到碳酸镧纳米晶体。First prepare 10wt% glycerol solution, 1.2mol/L ammonium bicarbonate solution, and 0.9mol/L lanthanum acetate solution for use, then take out 100ml lanthanum acetate solution, add 2ml glycerol solution, and stir to make it evenly mixed. Use an ice/water mixture water bath to control the temperature at 15°C, add 100ml of ammonium bicarbonate solution drop by drop, complete the addition in 20 minutes, stir and react for 5 minutes, then raise the temperature at a rate of 2°C/min until it stops at 25°C, and react at this temperature for 70 minutes , and then adding 0.5ml of Tween 40 with a concentration of 5wt%, and standing for 30min. Put the turbid liquid in a centrifuge for separation for 20 minutes, take out the sediment, wash it with water 4 times, and place the sediment in a crucible. The crucible containing the product was heated in a muffle furnace at a heating rate of 10°C/min until 250°C, baked at this temperature for 1 hour, and then cooled naturally to room temperature to obtain lanthanum carbonate nanocrystals.

实例4Example 4

首先配制2wt%乳糖溶液、0.6mol/L碳酸氢钠溶液、0.4mol/L硫酸化镧溶液待用,然后取出80ml碳酸镧溶液,加入3ml乳糖溶液,搅拌使之混合均匀。用冰/水混合物水浴控制温度为12℃,加入80ml碳酸氢钠溶液,搅拌反应5min,而后以3℃/min速度升温,直到30℃停止,在此温度下反应40min,然后加入0.5ml浓度为1wt%的吐温40,并放置30min。将浊液放入离心分离机中分离20min,取出沉降物,用水洗3遍,将得到的沉降物置于坩埚中。将盛有产物的坩埚放入马弗炉中加热,升温速率为5℃/min,直到150℃,在此温度下焙烧1小时,然后自然冷却至室温,得到碳酸镧纳米晶体。First prepare 2wt% lactose solution, 0.6mol/L sodium bicarbonate solution, and 0.4mol/L lanthanum sulfate solution for use, then take out 80ml of lanthanum carbonate solution, add 3ml of lactose solution, and stir to make it evenly mixed. Use an ice/water mixture water bath to control the temperature at 12°C, add 80ml of sodium bicarbonate solution, stir for 5 minutes, then raise the temperature at a rate of 3°C/min until it stops at 30°C, react at this temperature for 40 minutes, and then add 0.5ml of 1wt% Tween 40, and left for 30min. Put the turbid liquid in a centrifuge for separation for 20 minutes, take out the sediment, wash it with water 3 times, and place the obtained sediment in a crucible. The crucible containing the product was heated in a muffle furnace at a heating rate of 5°C/min until 150°C, baked at this temperature for 1 hour, and then cooled naturally to room temperature to obtain lanthanum carbonate nanocrystals.

实例5Example 5

首先配制1wt%聚氧乙烯溶液、2wt%聚乙烯醇、0.015mol/L碳酸氢钠溶液、0.01mol/L硫酸化镧溶液待用,然后取出100ml碳酸镧溶液,加入3ml聚氧乙烯溶液和3ml聚乙烯醇溶液,搅拌使之混合均匀。用水浴控制温度为30℃,加入100ml碳酸氢钠溶液,搅拌反应20min,而后以3℃/min速度升温,直到50℃停止,在此温度下反应40min,然后加入0.5ml浓度为1wt%的吐温40,并放置30min。将浊液放入离心分离机中分离20min,取出沉降物,用水洗3遍,将得到的沉降物置于坩埚中。将盛有产物的坩埚放入马弗炉中加热,升温速率为5℃/min,直到300℃,在此温度下焙烧1小时,然后自然冷却至室温,得到碳酸镧纳米晶体。First prepare 1wt% polyoxyethylene solution, 2wt% polyvinyl alcohol, 0.015mol/L sodium bicarbonate solution, 0.01mol/L lanthanum sulfate solution for use, then take out 100ml lanthanum carbonate solution, add 3ml polyoxyethylene solution and 3ml Polyvinyl alcohol solution, stir to make it evenly mixed. Control the temperature with a water bath to 30°C, add 100ml of sodium bicarbonate solution, stir and react for 20 minutes, then raise the temperature at a rate of 3°C/min until it stops at 50°C, react at this temperature for 40 minutes, and then add 0.5ml of 1 wt% spitan Temperature 40, and place for 30min. Put the turbid liquid in a centrifuge for separation for 20 minutes, take out the sediment, wash it with water 3 times, and place the obtained sediment in a crucible. The crucible containing the product was heated in a muffle furnace at a heating rate of 5°C/min until 300°C, baked at this temperature for 1 hour, and then cooled naturally to room temperature to obtain lanthanum carbonate nanocrystals.

实例6Example 6

首先配制0.5wt%明胶溶液、0.1wt%聚氧乙烯溶液、1wt%山梨醇、0.6mol/L碳酸钠溶液、0.4mol/L氯化镧溶液待用,然后取出50ml氯化镧溶液,加入20ml明胶、聚氧乙烯、山梨醇溶液,搅拌使之混合均匀。用冰/水混合物水浴控制温度为12℃,加入50ml碳酸钠溶液,搅拌反应15min,而后以3℃/min速度升温,直到30℃停止,在此温度下反应30min,然后加入1wt%的聚乙烯基吡咯烷酮0.1ml,并放置20min。将浊液放入离心分离机中分离30min(3000r/min下同),取出沉降物,用水洗3遍,将得到的沉降物置于坩埚中。将盛有产物的坩埚放入马弗炉中加热,升温速率为14℃/min,直到400℃,在此温度下焙烧1小时,然后自然冷却至室温,得到纳米碳酸镧晶体First prepare 0.5wt% gelatin solution, 0.1wt% polyoxyethylene solution, 1wt% sorbitol, 0.6mol/L sodium carbonate solution, 0.4mol/L lanthanum chloride solution for use, then take out 50ml lanthanum chloride solution, add 20ml Gelatin, polyoxyethylene, sorbitol solution, stir to make it evenly mixed. Use an ice/water mixture water bath to control the temperature at 12°C, add 50ml of sodium carbonate solution, stir for 15 minutes, then raise the temperature at a rate of 3°C/min until it stops at 30°C, react at this temperature for 30 minutes, and then add 1wt% polyethylene Base pyrrolidone 0.1ml, and left for 20min. Put the turbid liquid into a centrifuge for separation for 30 minutes (3000r/min, the same below), take out the sediment, wash with water 3 times, and place the obtained sediment in a crucible. Put the crucible containing the product into a muffle furnace and heat it at a rate of 14°C/min until 400°C, bake it at this temperature for 1 hour, and then cool it naturally to room temperature to obtain nano-lanthanum carbonate crystals

实例7Example 7

取12份上述制得的实例2中碳酸镧纳米晶体与38份甘露醇充分混合,然后与35份60℃下干燥3小时的微晶纤维素、3份PPVP、6份LSHPC混合均匀,并过100目筛,然后加入1份碳酸氢钠、2份微粉硅胶、1.5份硬脂酸镁、1份枸橼酸和0.5份橘子香精,并混合均匀,然后在5Mpa压力下压片,得到口腔崩解片。片硬度为3kg,体外崩解时限为53s。Get 12 parts of lanthanum carbonate nanocrystals and 38 parts of mannitol in the example 2 that above-mentioned make fully mix, then mix with 35 parts of microcrystalline cellulose, 3 parts of PPVP, 6 parts of LSHPC dried at 60 ℃ for 3 hours, and pass 100-mesh sieve, then add 1 part of sodium bicarbonate, 2 parts of micropowdered silica gel, 1.5 parts of magnesium stearate, 1 part of citric acid and 0.5 part of orange essence, mix well, and then compress the tablet under a pressure of 5Mpa to obtain oral disintegration solution piece. The tablet hardness is 3kg, and the in vitro disintegration time limit is 53s.

实例8Example 8

取7份上述制得的碳酸镧纳米晶体与24份木糖醇、15乳糖充分混合,然后与28份60℃下干燥3小时的微晶纤维素、11份LSHPC混合均匀,并过80目筛,然后加入5份碳酸氢钠、3份微粉硅胶、3份滑石粉、3份柠檬酸和1份甘草,并混合均匀,然后在10Mpa压力下压片,得到口腔崩解片。片硬度为5kg,体外崩解时限为75s。Get 7 parts of lanthanum carbonate nanocrystals prepared above and fully mix them with 24 parts of xylitol and 15 parts of lactose, then mix them evenly with 28 parts of microcrystalline cellulose dried at 60°C for 3 hours, and 11 parts of LSHPC, and pass through an 80-mesh sieve , then add 5 parts of sodium bicarbonate, 3 parts of micropowder silica gel, 3 parts of talcum powder, 3 parts of citric acid and 1 part of licorice, mix well, and then compress under a pressure of 10Mpa to obtain orally disintegrating tablets. The tablet hardness is 5kg, and the in vitro disintegration time limit is 75s.

实例9Example 9

取10份上述制得的碳酸镧纳米晶体与23份四丁醇、10乳糖充分混合,然后与36份60℃下干燥5小时的微晶纤维素、14份低取代羟丙纤维素混合均匀,并过80目筛,然后加入2份碳酸氢钠、2份微粉硅胶、1份硬脂酸镁、1份柠檬酸和1份甘草,并混合均匀,然后在7Mpa压力下压片,得到口腔崩解片。片硬度为4kg,体外崩解时限为15sGet 10 parts of above-mentioned prepared lanthanum carbonate nanocrystals and fully mix with 23 parts of tetrabutanol and 10 parts of lactose, then mix evenly with 36 parts of microcrystalline cellulose dried at 60° C. for 5 hours, and 14 parts of low-substituted hydroxypropyl cellulose, And pass through 80 mesh sieve, then add 2 parts of sodium bicarbonate, 2 parts of micropowder silica gel, 1 part of magnesium stearate, 1 part of citric acid and 1 part of licorice, mix well, and then compress under 7Mpa pressure to obtain oral disintegration solution piece. The tablet hardness is 4kg, and the in vitro disintegration time limit is 15s

实例10Example 10

取19份上述制得的碳酸镧纳米晶体与14份甘露醇、5份山梨醇、2份蔗糖充分混合,然后与42份60℃下干燥3小时的微晶纤维素、10份交联羧甲基纤维素钠(cCMC-Na)、2份交联羧甲基淀粉钠(CMS-Na)混合均匀,并过100目筛,然后加入1.5份碳酸氢钠、2份微粉硅胶、0.5份硬脂酸镁、1份枸橼酸和1份薄荷醇,并混合均匀,然后在3Mpa压力下压片,得到口腔崩解片。片硬度为3kg,体外崩解时限为38s。Get 19 parts of the lanthanum carbonate nanocrystals prepared above and fully mix them with 14 parts of mannitol, 5 parts of sorbitol, and 2 parts of sucrose, then mix them with 42 parts of microcrystalline cellulose dried at 60°C for 3 hours, 10 parts of croscarmellose Sodium cellulose cellulose (cCMC-Na), 2 parts of croscarmellose sodium starch (CMS-Na) were mixed evenly, and passed through a 100-mesh sieve, and then 1.5 parts of sodium bicarbonate, 2 parts of micropowdered silica gel, 0.5 part of stearin Magnesium acid, 1 part of citric acid and 1 part of menthol, and mixed uniformly, and then compressed under a pressure of 3Mpa to obtain orally disintegrating tablets. The tablet hardness is 3kg, and the in vitro disintegration time limit is 38s.

实例11Example 11

取22份上述制得的碳酸镧纳米晶体与25份木糖醇、16乳糖充分混合,然后与37份60℃下干燥3小时的微晶纤维素混合均匀,并过100目筛,并混合均匀,然后在10Mpa压力下压片,得到口腔崩解片。片硬度为5kg,体外崩解时限为83s。Get 22 parts of the lanthanum carbonate nanocrystals prepared above and fully mix them with 25 parts of xylitol and 16 parts of lactose, then mix them evenly with 37 parts of microcrystalline cellulose dried at 60°C for 3 hours, pass through a 100-mesh sieve, and mix them evenly , and then compressed under a pressure of 10Mpa to obtain orally disintegrating tablets. The tablet hardness is 5kg, and the in vitro disintegration time limit is 83s.

实例12Example 12

取16份上述制得的碳酸镧纳米晶体与24份木糖醇、21乳糖充分混合,然后与26份60℃下干燥4小时的微晶纤维素、10份LSHPC混合均匀,并过80目筛,然后加入2份微粉硅胶、1份滑石粉,并混合均匀,然后在10Mpa压力下压片,得到口腔崩解片。片硬度为5kg,体外崩解时限为46s。Get 16 parts of the lanthanum carbonate nanocrystals prepared above and fully mix them with 24 parts of xylitol and 21 parts of lactose, then mix them evenly with 26 parts of microcrystalline cellulose dried at 60°C for 4 hours, and 10 parts of LSHPC, and pass through an 80-mesh sieve , and then add 2 parts of micropowdered silica gel and 1 part of talc powder, mix well, and then compress the tablet under a pressure of 10Mpa to obtain an orally disintegrating tablet. The tablet hardness is 5kg, and the in vitro disintegration time limit is 46s.

实例13Example 13

取20份碳酸镧(威海佰德信新材料有限公司生产)与20份木糖醇、24蔗糖充分混合,然后与34份60℃下干燥5小时的微晶纤维素混合均匀,并过80目筛,然后加入1份微粉硅胶、1份滑石粉,并混合均匀,然后在10Mpa压力下压片,得到口腔崩解片。片硬度为4kg,体外崩解时限为59s。Get 20 parts of lanthanum carbonate (produced by Weihai Baidexin New Material Co., Ltd.), fully mix with 20 parts of xylitol and 24 parts of sucrose, then mix evenly with 34 parts of microcrystalline cellulose dried at 60°C for 5 hours, and pass through 80 mesh Sieve, then add 1 part of micropowder silica gel and 1 part of talc powder, mix well, and then compress the tablet under a pressure of 10 MPa to obtain an orally disintegrating tablet. The tablet hardness is 4kg, and the in vitro disintegration time limit is 59s.

实例14Example 14

取10份上述制得的碳酸镧纳米晶体与10份甘露醇、10份微晶纤维素、1份蔗糖、3份PPVP、0.5枸橼酸和5份聚维酮乙醇-水溶液(浓度为10wt%)充分混合均匀,过40目筛,在60℃下干燥4小时;然后与28份60℃下干燥3小时的微晶纤维素、12份LSHPC、1份PPVP、15份甘露醇、2份乳糖混合均匀,并过80目筛;然后加入1份碳酸氢钠、2份微粉硅胶、2份硬脂酸镁、1份枸橼酸和1份薄荷醇,并混合均匀,然后在5Mpa压力下压片,得到口腔崩解片。片硬度为3.5kg,体外崩解时限为58s。Get 10 parts of above-mentioned lanthanum carbonate nanocrystals and 10 parts of mannitol, 10 parts of microcrystalline cellulose, 1 part of sucrose, 3 parts of PPVP, 0.5 parts of citric acid and 5 parts of povidone ethanol-water solution (concentration is 10wt% ) were thoroughly mixed, passed through a 40-mesh sieve, and dried at 60°C for 4 hours; then mixed with 28 parts of microcrystalline cellulose dried at 60°C for 3 hours, 12 parts of LSHPC, 1 part of PPVP, 15 parts of mannitol, and 2 parts of lactose Mix well and pass through an 80-mesh sieve; then add 1 part of sodium bicarbonate, 2 parts of micropowdered silica gel, 2 parts of magnesium stearate, 1 part of citric acid and 1 part of menthol, mix well, and then press under a pressure of 5Mpa tablets to obtain orally disintegrating tablets. The tablet hardness is 3.5kg, and the in vitro disintegration time limit is 58s.

实例15Example 15

取15份上述制得的碳酸镧纳米晶体与14份甘露醇、12份微晶纤维素、1份蔗糖、5份LSHPC、1份交联羧甲基淀粉钠(CMS-Na)、0.5柠檬酸和1份PEG、2份糊精(浓度为25wt%的水溶液)充分混合均匀,过40目筛,在50℃下干燥6小时;然后与24份60℃下干燥3小时的微晶纤维素、7份LSHPC、3份PPVP、10份木糖醇、2份乳糖混合均匀,并过100目筛;然后加入0.5份碳酸氢钠、1.5份微粉硅胶、1份硬脂酸镁、0.5柠檬酸和0.5菠萝香精,并混合均匀,然后在4Mpa压力下压片,得到口腔崩解片。片硬度为3kg,体外崩解时限为49s。Get 15 parts of above-mentioned lanthanum carbonate nanocrystals and 14 parts of mannitol, 12 parts of microcrystalline cellulose, 1 part of sucrose, 5 parts of LSHPC, 1 part of croscarmellose sodium starch (CMS-Na), 0.5 parts of citric acid Mix well with 1 part of PEG and 2 parts of dextrin (aqueous solution with a concentration of 25wt%), pass through a 40-mesh sieve, and dry at 50°C for 6 hours; then dry with 24 parts of microcrystalline cellulose, Mix 7 parts of LSHPC, 3 parts of PPVP, 10 parts of xylitol, and 2 parts of lactose evenly, and pass through a 100-mesh sieve; then add 0.5 parts of sodium bicarbonate, 1.5 parts of micronized silica gel, 1 part of magnesium stearate, 0.5 parts of citric acid and 0.5 pineapple flavor, and mixed evenly, then compressed under 4Mpa pressure to obtain orally disintegrating tablets. The tablet hardness is 3kg, and the in vitro disintegration time limit is 49s.

实例16Example 16

取40份上述制得的碳酸镧纳米晶体与20份甘露醇、16份微晶纤维素充分混合均匀,过40目筛,在60℃下干燥5小时;然后与21份60℃下干燥3小时的微晶纤维素、3份聚乙二醇并过100目筛;混合均匀,然后在10Mpa压力下压片,得到口腔崩解片。片硬度为5kg,体外崩解时限为80s。Take 40 parts of lanthanum carbonate nanocrystals prepared above, mix well with 20 parts of mannitol, and 16 parts of microcrystalline cellulose, pass through a 40-mesh sieve, and dry at 60°C for 5 hours; then dry with 21 parts of 60°C for 3 hours microcrystalline cellulose, 3 parts of polyethylene glycol and passed through a 100-mesh sieve; mixed evenly, and then compressed under a pressure of 10Mpa to obtain an orally disintegrating tablet. The tablet hardness is 5kg, and the in vitro disintegration time limit is 80s.

实例17Example 17

取6份上述制得的碳酸镧纳米晶体与5份甘露醇、5份山梨醇、10份微晶纤维素、8交联羧甲基淀粉钠、5分低取代羟丙纤维素、1份蔗糖、2份PPVP、0.5柠檬酸和3份聚维酮乙醇-水溶液(浓度为10wt%)充分混合均匀,过40目筛,在60℃下干燥3小时;然后与20份60℃下干燥3小时的微晶纤维素、9份LSHPC、1份PPVP、15份甘露醇、1.5份乳糖混合均匀,并过80目筛;然后加入1份碳酸氢钠、0.5份微粉硅胶、4份硬脂酸镁、1.5份柠檬酸和1份薄荷醇,并混合均匀,然后在5Mpa压力下压片,得到口腔崩解片。片硬度为3.5kg,体外崩解时限为58s。Get 6 parts of above-mentioned lanthanum carbonate nanocrystals and 5 parts of mannitol, 5 parts of sorbitol, 10 parts of microcrystalline cellulose, 8 parts of croscarmellose sodium, 5 parts of low-substituted hydroxypropyl cellulose, and 1 part of sucrose , 2 parts of PPVP, 0.5 citric acid and 3 parts of povidone ethanol-water solution (concentration is 10wt%) are fully mixed, passed through a 40-mesh sieve, and dried at 60°C for 3 hours; then dried with 20 parts of 60°C for 3 hours Microcrystalline cellulose, 9 parts of LSHPC, 1 part of PPVP, 15 parts of mannitol, and 1.5 parts of lactose were mixed evenly and passed through an 80-mesh sieve; then 1 part of sodium bicarbonate, 0.5 parts of micropowder silica gel, and 4 parts of magnesium stearate were added , 1.5 parts of citric acid and 1 part of menthol, and mix uniformly, then compress the tablet under a pressure of 5Mpa to obtain an orally disintegrating tablet. The tablet hardness is 3.5kg, and the in vitro disintegration time limit is 58s.

本发明并不局限于实施例中所描述的技术,它的描述是说明性的,并非限制性的,本发明的权限由权利要求所限定,基于本技术领域人员依据本发明所能够变化、重组等方法得到的与本发明相关的技术,都在本发明的保护范围之内。The present invention is not limited to the technology described in the embodiment, its description is illustrative, not restrictive, the authority of the present invention is defined by the claims, based on those skilled in the art can change and reorganize according to the present invention The technologies related to the present invention obtained by such methods are all within the protection scope of the present invention.

Claims (7)

1.一种纳米碳酸镧口腔崩解片的制备方法:1. A preparation method of nanometer lanthanum carbonate orally disintegrating tablet: 1).配制制剂成分:1). Preparation ingredients: 纳米碳酸镧:            5-40份Nano lanthanum carbonate: 5-40 parts 崩解剂:                10-70份Disintegrant: 10-70 parts 填充剂:                15-60份Filler: 15-60 parts 矫味剂:                0-5份Flavoring agent: 0-5 parts 泡腾剂碳酸氢钠:        0-5份Effervescent sodium bicarbonate: 0-5 parts 助流剂微粉硅胶:        0-4份Glidant micropowder silica gel: 0-4 parts 润滑剂硬脂酸镁或滑石粉:0-2份Lubricants magnesium stearate or talc: 0-2 parts 粘接剂:                0.5-3份;Adhesive: 0.5-3 parts; 2)组分在40-80℃下干燥2-4小时,过40-100目筛,然后压片得到口腔崩解片;2) The components are dried at 40-80°C for 2-4 hours, passed through a 40-100 mesh sieve, and then compressed into tablets to obtain orally disintegrating tablets; 所述的纳米碳酸镧采用如下方法制备:Described nano-lanthanum carbonate adopts following method to prepare: 1)配制0.1-10wt%稳定剂溶液和0.01-0.9mol/L镧化合物溶液,并将两种溶液混合均匀,静置10-30分钟,将配制好的0.01-1.2mol/L碳酸盐溶液加入到上述混合溶液中,控制成核温度5-30℃,搅拌反应5-20分钟;然后在10-50℃和搅拌下继续反应30min-4h,停止搅拌,加入浓度为0.1-5wt%表面活性剂溶液,然后放置10-60分钟;1) Prepare 0.1-10wt% stabilizer solution and 0.01-0.9mol/L lanthanum compound solution, mix the two solutions evenly, let stand for 10-30 minutes, and prepare 0.01-1.2mol/L carbonate solution Add it to the above mixed solution, control the nucleation temperature at 5-30°C, stir and react for 5-20 minutes; then continue to react at 10-50°C and stir for 30min-4h, stop stirring, and add a concentration of 0.1-5wt% surface active agent solution, and then left for 10-60 minutes; 将上述所得产物离心沉降10-40min,并用蒸馏水洗2-4遍;然后将固体干燥产物在马弗炉中培烧1-5小时,温度控制在150-400℃,升温速率为5-10℃/min;Centrifuge the product obtained above for 10-40 minutes, and wash it with distilled water 2-4 times; then burn the solid dry product in a muffle furnace for 1-5 hours, the temperature is controlled at 150-400°C, and the heating rate is 5-10°C /min; 所述的稳定剂为天然大分子明胶、壳聚糖、海藻酸盐、胶原、淀粉或纤维素;或聚乙烯醇、聚羟基丁酸酯及共聚物、聚酸酐、聚乙烯基吡咯烷酮、聚氧乙烯、聚乙二醇;或木糖醇、山梨醇、甘露醇、丙三醇的多元醇;或蔗糖、乳糖、葡萄糖;他们一种或两种以上混合使用。The stabilizer is natural macromolecular gelatin, chitosan, alginate, collagen, starch or cellulose; or polyvinyl alcohol, polyhydroxybutyrate and copolymers, polyanhydrides, polyvinylpyrrolidone, polyoxygen Ethylene, polyethylene glycol; or polyols of xylitol, sorbitol, mannitol, and glycerin; or sucrose, lactose, glucose; one or more of them are used in combination. 2.如权利要求1所述的纳米碳酸镧口腔崩解片的制备方法,其特征是制得的纳米碳酸镧口腔崩解片压力为2-15Mpa,所得口腔崩解片硬度为2~5kg,体外崩解时间为20-80秒。2. the preparation method of nano-lanthanum carbonate orally disintegrating tablet as claimed in claim 1, it is characterized in that the pressure of the obtained nano-lanthanum carbonate orally disintegrating tablet is 2-15Mpa, and the gained orally disintegrating tablet hardness is 2~5kg, The in vitro disintegration time is 20-80 seconds. 3.如权利要求1或2所述的纳米碳酸镧口腔崩解片的制备方法,其特征是所述的崩解剂为交联羧甲基纤维素钠、交联羧甲基淀粉钠、低取代羟丙纤维素、交联聚乙烯吡咯烷酮或微晶纤维素的一种或两种以上的聚合物的组合。3. the preparation method of nanometer lanthanum carbonate orally disintegrating tablet as claimed in claim 1 or 2, it is characterized in that described disintegrant is cross-linked sodium carboxymethyl cellulose, cross-linked sodium carboxymethyl starch, low A combination of one or two or more polymers replacing hydroxypropyl cellulose, cross-linked polyvinylpyrrolidone or microcrystalline cellulose. 4.如权利要求1所述的碳酸镧纳米晶口腔崩解片的制备方法,其特征是所述的填充剂为甘露醇、四丁醇、乳糖、蔗糖、木糖醇或山梨醇的一种或两种以上的聚合物的组合。4. the preparation method of lanthanum carbonate nanocrystal orally disintegrating tablet as claimed in claim 1 is characterized in that described filler is a kind of of mannitol, tetrabutanol, lactose, sucrose, xylitol or sorbitol Or a combination of two or more polymers. 5.如权利要求1或2所述的碳酸镧纳米晶口腔崩解片的制备方法,其特征是所述的矫味剂为薄荷醇、薄荷油、甘草、柠檬酸、枸橼酸、酒石酸、肉桂或香精的一种或两种以上的聚合物的组合。5. the preparation method of lanthanum carbonate nanocrystal orally disintegrating tablet as claimed in claim 1 or 2 is characterized in that described corrective agent is menthol, peppermint oil, licorice, citric acid, citric acid, tartaric acid, A combination of one or more polymers of cinnamon or essence. 6.如权利要求1或2所述的纳米碳酸镧口腔崩解片的制备方法,其特征是所述的粘接剂为聚维酮、聚乙二醇、予糊化淀粉、糊精或甲基纤维素的一种或两种以上的聚合物的组合。6. the preparation method of nano-lanthanum carbonate orally disintegrating tablet as claimed in claim 1 or 2 is characterized in that described binding agent is povidone, polyethylene glycol, pregelatinized starch, dextrin or formazan A combination of one or two or more polymers based on cellulose. 7.如权利要求1或2所述的纳米碳酸镧口腔崩解片的制备方法,其特征是所述的镧化合物为氯化镧、硝酸镧、硫酸镧、醋酸镧或草酸镧;碳酸盐为碳酸钠、碳酸钾、碳酸氨、碳酸氢纳、碳酸氢钾或碳酸氢氨;表面活性剂为十二烷基磺酸钠、司盘80、司盘60或吐温40。7. the preparation method of nano-lanthanum carbonate orally disintegrating tablet as claimed in claim 1 or 2 is characterized in that described lanthanum compound is lanthanum chloride, lanthanum nitrate, lanthanum sulfate, lanthanum acetate or lanthanum oxalate; Carbonate It is sodium carbonate, potassium carbonate, ammonium carbonate, sodium bicarbonate, potassium bicarbonate or ammonium bicarbonate; the surfactant is sodium dodecyl sulfonate, Span 80, Span 60 or Tween 40.
CN2006100138360A 2006-05-24 2006-05-24 Nano lanthanum carbonate and orally disintegrating tablet and preparation method Expired - Fee Related CN101077338B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2006100138360A CN101077338B (en) 2006-05-24 2006-05-24 Nano lanthanum carbonate and orally disintegrating tablet and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2006100138360A CN101077338B (en) 2006-05-24 2006-05-24 Nano lanthanum carbonate and orally disintegrating tablet and preparation method

Publications (2)

Publication Number Publication Date
CN101077338A CN101077338A (en) 2007-11-28
CN101077338B true CN101077338B (en) 2012-06-20

Family

ID=38905110

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006100138360A Expired - Fee Related CN101077338B (en) 2006-05-24 2006-05-24 Nano lanthanum carbonate and orally disintegrating tablet and preparation method

Country Status (1)

Country Link
CN (1) CN101077338B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969497A (en) * 2018-10-12 2018-12-11 沈阳华泰药物研究有限公司 A kind of lanthanum carbonate tablet composition and preparation method thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011051968A2 (en) * 2009-10-26 2011-05-05 Alkem Laboratories Ltd. Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof
CA3224506A1 (en) * 2010-05-12 2011-11-17 Unicycive Therapeutics, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
CN103145170A (en) * 2013-03-27 2013-06-12 吉首大学 Method for preparing lanthanum carbonate by reacting supercritical carbon dioxide and lanthanum oxide
CN104473963B (en) * 2014-12-24 2017-10-10 厦门科明达科技有限公司 The preparation method of rare earth chemistry medicine lanthanum carbonate chewable tablets
CN105568262B (en) * 2015-12-28 2017-12-19 重庆大学 A kind of preparation method of wear-resistant, damage resistant, corrosion resistant metal surface film layer
CN107213126B (en) * 2017-05-17 2020-06-23 西安棣加生物科技有限公司 Method for preparing oral rapidly disintegrating tablet for treating hyperphosphatemia by 3D printing technology
JP2020033303A (en) * 2018-08-30 2020-03-05 コーアイセイ株式会社 Orally quick disintegrating tablet containing lanthanum carbonate and being stable
CN111620363A (en) * 2020-06-13 2020-09-04 南京卡文迪许生物工程技术有限公司 Preparation method of lanthanum carbonate tetrahydrate and product thereof
CN112315916B (en) * 2020-11-12 2021-07-06 东莞市金美济药业有限公司 Traditional Chinese medicine granules for treating osteoarthritis and preparation method thereof
CN115813867B (en) * 2022-12-01 2024-05-24 山东齐都药业有限公司 Lanthanum carbonate freeze-dried tablet and preparation method thereof
CN116036037B (en) * 2023-02-06 2025-03-07 青岛润昕德生物医药有限公司 Lanthanum polystyrene sulfonate sheet and preparation method thereof
CN119454898B (en) * 2025-01-14 2025-07-08 佛山市口腔医院(佛山市牙病防治指导中心) A sedation-maintaining agent administered via oral mucosa and a preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1184428A (en) * 1995-03-25 1998-06-10 约翰逊马西有限公司 Pharmaceutical composition containing selected lanthanum carbonate hydrates
CN1706372A (en) * 2005-05-24 2005-12-14 中国人民解放军第二军医大学 Sodium ferulate orally disintegrating tablet and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1184428A (en) * 1995-03-25 1998-06-10 约翰逊马西有限公司 Pharmaceutical composition containing selected lanthanum carbonate hydrates
CN1706372A (en) * 2005-05-24 2005-12-14 中国人民解放军第二军医大学 Sodium ferulate orally disintegrating tablet and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969497A (en) * 2018-10-12 2018-12-11 沈阳华泰药物研究有限公司 A kind of lanthanum carbonate tablet composition and preparation method thereof

Also Published As

Publication number Publication date
CN101077338A (en) 2007-11-28

Similar Documents

Publication Publication Date Title
CN101077338B (en) Nano lanthanum carbonate and orally disintegrating tablet and preparation method
JP5209492B2 (en) Pharmaceutical formulations for the production of fast-disintegrating tablets
KR101565621B1 (en) Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
WO2005037319A1 (en) Composition for tablet rapidly disintegrable in mouth
CN105816437A (en) A pharmaceutical preparation of palbociclib and its preparation method
JP5342028B2 (en) Orally disintegrating tablets
JPWO2007029376A1 (en) Orally rapidly disintegrating tablets
CN102716097A (en) Method for controlling medicament release rate of orally disintegrating tablet
WO2022012172A1 (en) Oral sustained-release composition for insoluble drug, and preparation method thereof
WO2020249001A1 (en) Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor
JPWO2011118453A1 (en) Solid preparation
WO2019151405A1 (en) Tablets and method for producing same
JP2012515723A (en) Disintegrating preparation of lanthanum carbonate
WO2024140984A1 (en) Controlled release tablet of loxoprofen sodium, preparation method, and use
CN101564402A (en) Rehabilitation new dispersing tablet and preparation method thereof
JP6623753B2 (en) Orally disintegrating tablets containing lanthanum carbonate
CN103393612B (en) Preparation method for enalapril maleate orally disintegrating tablets
CN102846573B (en) Silibinin double-layer slow-release tablets and preparation method thereof
CN102727456B (en) Drug port cavity disintegrating tablet and preparation method thereof
CN116036079A (en) Pharmaceutical composition of compound and preparation method thereof
JPH04243828A (en) Solid oral ifosfamide pharmaceutical composition and method for producing the same
KR101093447B1 (en) Pentoxifylline sustained-release composition and preparation method
CN103070842B (en) Preparation method of miglitol sustained release tablet
WO2018192000A1 (en) Osmotic pump tablet of perindopril and salt thereof and preparation method of same
JP2018193349A (en) Orally disintegrating tablet containing lanthanum carbonate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120620

Termination date: 20130524